title: Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary.
authors.affiliation: NMR Research Unit, Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, London, UK/National Institute for Health Research (NIHR) Biomedical Research Centre, University College London Hospitals (UCLH), London, UK d.chard@ucl.ac.uk.
authors.forename: Declan
authors.initials: D
authors.lastname: Chard
mesh_terms: D001284:Atrophy; D001921:Brain; D001927:Brain Diseases; D006801:Humans; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis